Insider Transactions in Q2 2021 at Singular Genomics Systems, Inc. (OMIC)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2021
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,500,000
+22.45%
|
$33,000,000
$22.0 P/Share
|
|
Jun 01
2021
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
7,612,019
+35.86%
|
$129,404,323
$17.6 P/Share
|
|
Jun 01
2021
|
Kim P. Kamdar |
BUY
Conversion of derivative security
|
Indirect |
4,395,633
+49.44%
|
-
|
|
Jun 01
2021
|
Alexandria Venture Investments, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,645,985
+50.0%
|
-
|
|
Jun 01
2021
|
Andrew Spaventa Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
889,028
+33.15%
|
$15,113,476
$17.6 P/Share
|
|
May 20
2021
|
Michael J Pellini |
BUY
Conversion of derivative security
|
Indirect |
96,944
+50.0%
|
-
|